Catecholamine metabolism: A contemporary view with implications for physiology and medicine

被引:734
作者
Eisenhofer, G [1 ]
Kopin, IJ [1 ]
Goldstein, DS [1 ]
机构
[1] Natl Inst Neurol Disorders & Stroke, Clin Neurocardiol Sect, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1124/pr.56.3.1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article provides an update about catecholamine metabolism, with emphasis on correcting common misconceptions relevant to catecholamine systems in health and disease. Importantly, most metabolism of catecholamines takes place within the same cells where the amines are synthesized. This mainly occurs secondary to leakage of catecholamines from vesicular stores into the cytoplasm. These stores exist in a highly dynamic equilibrium, with passive outward leakage counterbalanced by inward active transport controlled by vesicular monoamine transporters. In catecholaminergic neurons, the presence of monoamine oxidase leads to formation of reactive catecholaldehydes. Production of these toxic aldehydes depends on the dynamics of vesicular-axoplasmic monoamine exchange and enzyme-catalyzed conversion to nontoxic acids or alcohols. In sympathetic nerves, the aldehyde produced from norepinephrine is converted to 3,4-dihydroxyphenylglycol, not 3,4-dihydroxymandelic acid. Subsequent extraneuronal O-methylation consequently leads to production of 3-methoxy-4-hydroxyphenylglycol, not vanillylmandelic acid. Vanillylmandelic acid is instead formed in the liver by oxidation of 3-methoxy-4-hydroxyphenylglycol catalyzed by alcohol and aldehyde dehydrogenases. Compared to intraneuronal deamination, extraneuronal O-methylation of norepinephrine and epinephrine to metanephrines represent minor pathways of metabolism. The single largest source of metanephrines is the adrenal medulla. Similarly, pheochromocytoma tumor cells produce large amounts of metanephrines from catecholamines leaking from stores. Thus, these metabolites are particularly useful for detecting pheochromocytomas. The large contribution of intraneuronal deamination to catecholamine turnover, and dependence of this on the vesicular-axoplasmic monoamine exchange process, helps explain how synthesis, release, metabolism, turnover, and stores of catecholamines are regulated in a coordinated fashion during stress and in disease states.
引用
收藏
页码:331 / 349
页数:19
相关论文
共 226 条
[1]   Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion [J].
Akiyama, T ;
Yamazaki, T .
CARDIOVASCULAR RESEARCH, 2001, 49 (01) :78-85
[2]   Sympathetic discharge to mesenteric organs and the liver - Evidence for substantial mesenteric organ norepinephrine spillover [J].
Aneman, A ;
Eisenhofer, G ;
Olbe, L ;
Dalenback, J ;
Nitescu, P ;
Fandriks, L ;
Friberg, P .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1640-1646
[3]   HEPATOMESENTERIC RELEASE AND REMOVAL OF NOREPINEPHRINE IN SWINE [J].
ANEMAN, A ;
EISENHOFER, G ;
FANDRIKS, L ;
FRIBERG, P .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1995, 268 (04) :R924-R930
[4]   DETERMINATION OF HOMOVANILLIC-ACID TURNOVER IN MAN [J].
ANGGARD, E ;
LEWANDER, T ;
SJOQUIST, B .
LIFE SCIENCES, 1974, 15 (01) :111-122
[5]  
ARMSTRONG MD, 1959, PHARMACOL REV, V11, P394
[6]   3-METHOXY-4-HYDROXY-D-MANDELIC ACID, A URINARY METABOLITE OF NOREPINEPHRINE [J].
ARMSTRONG, MD ;
MCMILLAN, A ;
SHAW, KNF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1957, 25 (02) :422-423
[7]   3-METHOXY-4-HYDROXYPHENYLGLYCOL SULFATE, A NEW METABOLITE OF EPINEPHRINE AND NOREPINEPHRINE [J].
AXELROD, J ;
KOPIN, IJ ;
MANN, JD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1959, 36 (02) :576-577
[8]   The neuronal norepinephrine transporter in experimental heart failure:: Evidence for a posttranscriptional downregulation [J].
Backs, J ;
Haunstetter, A ;
Gerber, SH ;
Metz, J ;
Borst, MM ;
Strasser, RH ;
Kübler, W ;
Haass, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (03) :461-472
[9]   TRANSMURAL HETEROGENEITY OF NOREPINEPHRINE UPTAKE IN FAILING HUMAN HEARTS [J].
BEAU, SL ;
SAFFITZ, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (03) :579-585
[10]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306